Company / Current Liabilities
VitaNova Life Sciences Corp Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$347.6K
FY2025
5-year range
$58.1K / $347.6K
FY2021-FY2025
Trend
+153.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 3 consecutive years, from $58,091 in FY2022 to $347,567 in FY2025.
Based on SEC 10-K filings.
$347,567 in FY2025 with a 5-year CAGR of +23.2%.
Increased from $67,943 to $347,567 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +81.5%
- 5-Year CAGR
- +23.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- VitaNova Life Sciences Corp's current liabilities has grown for 3 consecutive years.
- 5-year CAGR of +23.2%, indicating consistent growth.
- In FY2025, current liabilities increased 153.8% year-over-year.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $347.6K | +153.8% |
| FY2024 | $136.9K | +101.5% |
| FY2023 | $67.9K | +17.0% |
| FY2022 | $58.1K | -66.7% |
| FY2021 | $174.7K | +42.5% |
| FY2020 | $122.6K | +144.0% |
| FY2019 | $50.2K | - |
| FY2018 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026